https://www.selleckchem.com/products/ru-521.html
Oestrogen deficiency is an aetiological factor of postmenopausal osteoporosis (PMO), which not only decreases bone density in vertebrae and long bone but also aggravates inflammatory alveolar bone loss. Recent evidence has suggested the critical role of gut microbiota in osteoimmunology and its influence on bone metabolisms. The present study aimed to evaluate the therapeutic effects of probiotics on alveolar bone loss under oestrogen-deficient condition. Inflammatory alveolar bone loss was established in ovariectomized (OVX) rats, and r
Gefällt mir
Kommentar
Teilen
